Logo

Thermo Fisher's Axiom Precision Medicine Research Array

Jul 07, 2016

Thermo Fisher Scientific has launched its Axiom Precision Medicine Research array. It is a broad genotyping resource designed to enable research on a variety of health questions related to common and rare inherited diseases, genetic risk profiling, immune response, and pharmacogenomics research. The array contains about 800,000 pan-ethnic imputation markers selected for highest genomic coverage at various 1000 Genomes phase 3 minor allele frequency ranges, and more than 100,000 relevant gene variants from broadly referenced public databases, including ClinVar, CPIC, PharmaGKB, and PharmaADME.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.